RAG-17, a Novel siRNA Therapy for SOD1-ALS: Safety and Preliminary Efficacy from a First-in-human Trial

Frequency and Predictors of Cognitive Deterioration in Amyotrophic Lateral Sclerosis: A Population-based Longitudinal Study